Zhixin Xie, Ph.D. - Publications

Affiliations: 
2000 University of Idaho, Moscow, ID, United States 
Area:
Plant Pathology Agriculture, Molecular Biology, Plant Physiology

65 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Liang H, Li H, Xie Z, Jin T, Chen Y, Lv Z, Tan X, Li J, Han G, He W, Qiu N, Jiang M, Zhou J, Xia H, Zhan Y, et al. Quantitative multiplex immunofluorescence analysis identifies infiltrating PD1 CD8 and CD8 T cells as predictive of response to neoadjuvant chemotherapy in breast cancer. Thoracic Cancer. PMID 32894006 DOI: 10.1111/1759-7714.13639  0.48
2020 Liu SY, Sun H, Zhou JY, Jie GL, Xie Z, Shao Y, Zhang X, Ye JY, Chen CX, Zhang XC, Zhou Q, Yang JJ, Wu YL. Clinical characteristics and prognostic value of the mutation in Chinese non-small cell lung cancer patients. Biomarker Research. 8: 22. PMID 32607238 DOI: 10.1186/s40364-020-00199-z  0.6
2019 Yin K, Feng HB, Li LL, Chen Y, Xie Z, Lv ZY, Guo WB, Lu DX, Yang XN, Yan WQ, Wu YL, Zhang XC. Low frequency of mutation of epidermal growth factor receptor (EGFR) and arrangement of anaplastic lymphoma kinase (ALK) in primary pulmonary lymphoepithelioma-like carcinoma. Thoracic Cancer. PMID 31794146 DOI: 10.1111/1759-7714.13271  0.6
2019 Zhang C, Zhang J, Xu FP, Wang YG, Xie Z, Su J, Dong S, Nie Q, Shao Y, Zhou Q, Yang JJ, Yang XN, Zhang XC, Li Z, Wu YL, et al. Genomic Landscape and Immune Microenvironment Features of Preinvasive and Early-Invasive Lung Adenocarcinoma. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 31446140 DOI: 10.1016/j.jtho.2019.07.031  0.6
2019 Zhang YC, Chen ZH, Zhang XC, Xu CR, Yan HH, Xie Z, Chuai SK, Ye JY, Han-Zhang H, Zhang Z, Bai XY, Su J, Gan B, Yang JJ, Li WF, et al. Analysis of resistance mechanisms to abivertinib, a third-generation EGFR tyrosine kinase inhibitor, in patients with EGFR T790M-positive non-small cell lung cancer from a phase I trial. Ebiomedicine. PMID 31027916 DOI: 10.1016/j.ebiom.2019.04.030  0.6
2019 Guo L, Chen Z, Xu C, Zhang X, Yan H, Su J, Yang J, Xie Z, Guo W, Li F, Wu Y, Zhou Q. Intratumoral heterogeneity of EGFR-activating mutations in advanced NSCLC patients at the single-cell level. Bmc Cancer. 19: 369. PMID 31014278 DOI: 10.1186/s12885-019-5555-y  0.6
2019 Li L, Liang Y, Hong J, Lan L, Xiao H, Xie Z. The effectiveness of topical therapy combined with 308-nm excimer laser on vitiligo compared to excimer laser monotherapy in pediatric patients. Pediatric Dermatology. 36: e53-e55. PMID 30520111 DOI: 10.1111/pde.13726  0.4
2018 Zhang Q, Xie Z, Zhang R, Xu P, Liu H, Yang HQ, Doblin MS, Bacic A, Li L. Blue light regulates secondary cell wall thickening via MYC2/MYC4 activation of the NST1-directed transcriptional network in Arabidopsis. The Plant Cell. PMID 30242037 DOI: 10.1105/tpc.18.00315  0.4
2018 Su S, Dong ZY, Xie Z, Yan LX, Li YF, Su J, Liu SY, Yin K, Chen RL, Huang SM, Chen ZH, Yang JJ, Tu HY, Zhou Q, Zhong WZ, et al. Strong PD-L1 expression predicts poor response and de novo resistance to EGFR TKIs among non-small cell lung cancer patients with EGFR mutation. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 30056164 DOI: 10.1016/j.jtho.2018.07.016  0.6
2018 Li L, Wang C, Wei M, Huang Q, Wei L, Pan N, Xie Z. Mohs micrographic surgery combined local flaps in treatment of EMPD: A retrospective case. Dermatologic Therapy. e12663. PMID 30028568 DOI: 10.1111/dth.12663  0.4
2018 Li L, Hong J, Lan L, Xie Z, Liang Y, Chen H, Pan N. The effectiveness of combination therapy with 308-nm excimer laser in vitiligo in Han Chinese People. The Australasian Journal of Dermatology. PMID 29974452 DOI: 10.1111/ajd.12883  0.4
2017 Su J, Zhong W, Zhang X, Huang Y, Yan H, Yang J, Dong Z, Xie Z, Zhou Q, Huang X, Lu D, Yan W, Wu YL. Molecular characteristics and clinical outcomes of EGFR exon 19 indel subtypes to EGFR TKIs in NSCLC patients. Oncotarget. 8: 111246-111257. PMID 29340050 DOI: 10.18632/oncotarget.22768  0.6
2017 Huang Y, Su J, Huang X, Lu D, Xie Z, Yang S, Guo W, Lv Z, Wu H, Zhang X. [Detection of UGT1A1*28 Polymorphism Using Fragment Analysis]. Zhongguo Fei Ai Za Zhi = Chinese Journal of Lung Cancer. 20: 817-821. PMID 29277179 DOI: 10.3779/j.issn.1009-3419.2017.12.04  0.6
2017 Wu SP, Liao RQ, Tu HY, Wang WJ, Dong ZY, Huang SM, Guo WB, Gou LY, Sun HW, Zhang Q, Xie Z, Yan LX, Su J, Yang JJ, Zhong WZ, et al. Stromal PD-L1+regulatory T cells and PD-1+CD8+ T cells define the response of different subsets of non-small-cell lung cancer to PD-1/PD-L1 blockade immunotherapy. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 29269008 DOI: 10.1016/j.jtho.2017.11.132  0.6
2017 Qiao H, Xie Z, Jia J. Pediatric premedication: a double-blind randomized trial of dexmedetomidine or ketamine alone versus a combination of dexmedetomidine and ketamine. Bmc Anesthesiology. 17: 158. PMID 29187151 DOI: 10.1186/s12871-017-0454-8  0.36
2017 Dong ZY, Zhang C, Li YF, Su J, Xie Z, Liu SY, Yan LX, Chen ZH, Yang XN, Lin JT, Tu HY, Yang JJ, Zhou Q, Sun YL, Zhong WZ, et al. Genetic and immune profiles of solid predominant lung adenocarcinoma reveal potential immunotherapeutic strategies. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 29127022 DOI: 10.1016/j.jtho.2017.10.020  0.6
2017 Chen T, Huang Y, Liu R, Xie Z, Chen S, Hu G. Evaluating the effects of common control measures for influenza A (H1N1) outbreak at school in China: A modeling study. Plos One. 12: e0177672. PMID 28542360 DOI: 10.1371/journal.pone.0177672  0.32
2017 Li AN, Yang J, Zhang XC, Zhang Z, Su J, Gou LY, Bai Y, Zhou Q, Yang Z, Han-Zhang H, Zhong W, Chuai S, Zhang Q, Xie Z, Gao HF, et al. Acquired MET Y1248H and D1246N mutations mediate resistance to MET inhibitors in non-small cell lung cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 28396313 DOI: 10.1158/1078-0432.CCR-16-3273  0.6
2016 Dong ZY, Zhong W, Zhang XC, Su J, Xie Z, Liu SY, Tu HY, Chen HJ, Sun YL, Zhou Q, Yang J, Yang X, Lin JX, Yan H, Zhai HR, et al. Potential Predictive Value of TP53 and KRAS Mutation Status for Response to PD-1 Blockade Immunotherapy in Lung Adenocarcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 28039262 DOI: 10.1158/1078-0432.CCR-16-2554  0.6
2016 Chen T, Chen T, Liu R, Xu C, Wang D, Chen F, Zhu W, Zhang X, Yang J, Wang L, Xie Z, Chen Y, Bai T, Li Y, Wang Z, et al. Transmissibility of the Influenza Virus during Influenza Outbreaks and Related Asymptomatic Infection in Mainland China, 2005-2013. Plos One. 11: e0166180. PMID 27880774 DOI: 10.1371/journal.pone.0166180  0.36
2016 Lou NN, Zhang XC, Chen HJ, Zhou Q, Yan LX, Xie Z, Su J, Chen ZH, Tu HY, Yan HH, Wang Z, Xu CR, Jiang BY, Wang BC, Bai XY, et al. Clinical outcomes of advanced non-small-cell lung cancer patients with EGFR mutation, ALK rearrangement and EGFR/ALK co-alterations. Oncotarget. PMID 27533086 DOI: 10.18632/oncotarget.11218  0.6
2016 Gao HF, Li AN, Yang JJ, Chen ZH, Xie Z, Zhang XC, Su J, Lou NN, Yan HH, Han JF, Wu YL. Soluble c-Met Levels Correlated With Tissue c-Met Protein Expression in Patients With Advanced Non-Small-Cell Lung Cancer. Clinical Lung Cancer. PMID 27461774 DOI: 10.1016/j.cllc.2016.06.008  0.6
2016 Gou LY, Li AN, Yang JJ, Zhang XC, Su J, Yan HH, Xie Z, Lou NN, Liu SY, Dong ZY, Gao HF, Zhou Q, Zhong WZ, Xu CR, Wu YL. The coexistence of MET over-expression and an EGFR T790M mutation is related to acquired resistance to EGFR tyrosine kinase inhibitors in advanced non-small cell lung cancer. Oncotarget. PMID 27259997 DOI: 10.18632/oncotarget.9697  0.56
2016 Zhang C, Xie Z, Li X, Chen J, Feng J, Lang Y, Yang W, Li W, Chen Z, Yao J, Cao Z, Wu Y. Molecular basis for the toxin insensitivity of scorpion voltage-gated potassium channel MmKv1. The Biochemical Journal. PMID 26951716 DOI: 10.1042/BCJ20160178  0.36
2016 Bai XY, Zhang XC, Yang SQ, An SJ, Chen ZH, Su J, Xie Z, Gou LY, Wu YL. Blockade of Hedgehog Signaling Synergistically Increases Sensitivity to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer Cell Lines. Plos One. 11: e0149370. PMID 26943330 DOI: 10.1371/journal.pone.0149370  0.56
2016 Niu FY, Zhou Q, Yang JJ, Zhong WZ, Chen ZH, Deng W, He YY, Chen HJ, Zeng Z, Ke EE, Zhao N, Zhang N, Sun HW, Zhang QY, Xie Z, et al. Distribution and prognosis of uncommon metastases from non-small cell lung cancer. Bmc Cancer. 16: 149. PMID 26911831 DOI: 10.1186/s12885-016-2169-5  0.56
2016 Feng J, Xie Z, Yang W, Zhao Y, Xiang F, Cao Z, Li W, Chen Z, Wu Y. Human beta-defensin 1, a new animal toxin-like blocker of potassium channel. Toxicon : Official Journal of the International Society On Toxinology. PMID 26854370 DOI: 10.1016/j.toxicon.2016.02.007  0.36
2016 Meng L, Xie Z, Zhang Q, Li Y, Yang F, Chen Z, Li W, Cao Z, Wu Y. Scorpion potassium channel-blocking defensin highlights a functional link with neurotoxin. The Journal of Biological Chemistry. PMID 26817841 DOI: 10.1074/jbc.M115.680611  0.36
2015 Wu L, Xue L, Li C, Lv X, Chen Z, Guo M, Xie Z. A Geospatial Information Grid Framework for Geological Survey. Plos One. 10: e0145312. PMID 26710255 DOI: 10.1371/journal.pone.0145312  0.32
2015 Han JF, An SJ, Su WM, Chen ZH, Su J, Yan HH, Guo WB, Chen SL, Huang Y, Xie Z, Lan Q, Rothman N, Wu YL, Yang JJ. Polymorphism of rs9387478 correlates with overall survival in female nonsmoking patients with lung cancer. The International Journal of Biological Markers. 0. PMID 26689248 DOI: 10.5301/jbm.5000180  0.6
2015 Huang JQ, Liang HL, Zhang XC, Xie Z, Jin TE. Synergistic antitumor activity of pro-apoptotic agent PAC-1 with cisplatinum by the activation of CASP3 in pulmonary adenocarcinoma cell line H1299. Asia-Pacific Journal of Clinical Oncology. PMID 26620316 DOI: 10.1111/ajco.12419  0.48
2015 Yang LL, Zhang XC, Chuai SK, Chen ZH, Xie Z, Guo WB, Chen SL, Lei YY, Guo LH, Gou L, Sun HW, Zhang Q, Yang JJ, Tu HY, Su J, et al. Integrative Analyses of Lung Squamous Cell Carcinoma in Ten Chinese Patients with Transcriptome Sequencing. Journal of Genetics and Genomics = Yi Chuan Xue Bao. 42: 579-87. PMID 26554911 DOI: 10.1016/j.jgg.2015.09.007  0.6
2015 Lei YY, Yang JJ, Zhang XC, Zhong WZ, Zhou Q, Tu HY, Tian HX, Guo WB, Yang LL, Yan HH, Chen HJ, Xie Z, Su J, Han JF, Wu YL. Anaplastic Lymphoma Kinase Variants and the Percentage of ALK-Positive Tumor Cells and the Efficacy of Crizotinib in Advanced NSCLC. Clinical Lung Cancer. PMID 26454342 DOI: 10.1016/j.cllc.2015.09.002  0.6
2015 Hu Y, Chen J, Wang B, Yang W, Zhang C, Hu J, Xie Z, Cao Z, Li W, Wu Y, Chen Z. Engineering a peptide inhibitor towards the KCNQ1/KCNE1 potassium channel (IKs). Peptides. 71: 77-83. PMID 26188173 DOI: 10.1016/j.peptides.2015.07.002  0.36
2015 Xie Z, Feng J, Yang W, Xiang F, Yang F, Zhao Y, Cao Z, Li W, Chen Z, Wu Y. Human α-defensins are immune-related Kv1.3 channel inhibitors: new support for their roles in adaptive immunity. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. PMID 26148969 DOI: 10.1096/fj.15-274787  0.36
2015 Chen Z, Hu Y, Hong J, Hu J, Yang W, Xiang F, Yang F, Xie Z, Cao Z, Li W, Lin D, Wu Y. Toxin acidic residue evolutionary function-guided design of de novo peptide drugs for the immunotherapeutic target, the Kv1.3 channel. Scientific Reports. 5: 9881. PMID 25955787 DOI: 10.1038/srep09881  0.4
2015 Feng J, Yang W, Xie Z, Xiang F, Cao Z, Li W, Hu H, Chen Z, Wu Y. Kv Channel S1-S2 Linker Working as a Binding Site of Human β-Defensin 2 for Channel Activation Modulation. The Journal of Biological Chemistry. 290: 15487-95. PMID 25944908 DOI: 10.1074/jbc.M115.639500  0.36
2015 Wang H, Huang C, Dong J, Yao Y, Xie Z, Liu X, Zhang W, Fang F, Chen Z. Complete protection of mice against lethal murine cytomegalovirus challenge by immunization with DNA vaccines encoding envelope glycoprotein complex III antigens gH, gL and gO. Plos One. 10: e0119964. PMID 25803721 DOI: 10.1371/journal.pone.0119964  0.32
2015 Su WM, Chen ZH, Zhang XC, Su J, Xie Z, Yan HH, Yang JJ, Chen HJ, Zhou Q, Zhong WZ, Guo WB, Chen SL, Wu YL. Single nucleotide polymorphisms in VTI1A gene contribute to the susceptibility of Chinese population to non-small cell lung cancer. The International Journal of Biological Markers. 0. PMID 25744365 DOI: 10.5301/jbm.5000140  0.6
2015 Zheng M, Liu F, Shen Y, Wang S, Xu W, Fang F, Sun B, Xie Z, Chen Z. Cross-protection against influenza virus infection by intranasal administration of nucleoprotein-based vaccine with compound 48/80 adjuvant. Human Vaccines & Immunotherapeutics. 11: 397-406. PMID 25607884 DOI: 10.4161/21645515.2014.995056  0.32
2015 Liu N, Niu G, Xie Z, Chen Z, Itzek A, Kreth J, Gillaspy A, Zeng L, Burne R, Qi F, Merritt J. The Streptococcus mutans irvA gene encodes a trans-acting riboregulatory mRNA. Molecular Cell. 57: 179-90. PMID 25574948 DOI: 10.1016/j.molcel.2014.11.003  0.32
2015 Xiang F, Xie Z, Feng J, Yang W, Cao Z, Li W, Chen Z, Wu Y. Plectasin, first animal toxin-like fungal defensin blocking potassium channels through recognizing channel pore region. Toxins. 7: 34-42. PMID 25568977 DOI: 10.3390/toxins7010034  0.36
2015 Zhao N, Zheng SY, Yang JJ, Zhang XC, Xie Z, Xie B, Su J, Chen ZH, Chen SL, Zhang N, Lou NN, Dong S, Wu YL. Lung adenocarcinoma harboring concomitant EGFR mutation and EML4-ALK fusion that benefits from three kinds of tyrosine kinase inhibitors: a case report and literature review. Clinical Lung Cancer. 16: e5-9. PMID 25496960 DOI: 10.1016/j.cllc.2014.11.001  0.6
2015 Yang W, Feng J, Xiang F, Xie Z, Zhang G, Sabatier JM, Cao Z, Li W, Chen Z, Wu Y. Endogenous animal toxin-like human β-defensin 2 inhibits own K(+) channels through interaction with channel extracellular pore region. Cellular and Molecular Life Sciences : Cmls. 72: 845-53. PMID 25238780 DOI: 10.1007/s00018-014-1715-z  0.36
2015 Li A, Niu FY, Han JF, Lou NN, Yang JJ, Zhang XC, Zhou Q, Xie Z, Su J, Zhao N, Huang Y, Wu YL. Predictive and prognostic value of de novo MET expression in patients with advanced non-small-cell lung cancer Lung Cancer. 90: 375-380. DOI: 10.1016/j.lungcan.2015.10.021  0.6
2014 Zhang N, Yang JJ, Zhang XC, Xie Z, Wang BC, Tu HY, Jiang BY, Wu YL. Responses to crizotinib in a patient with c-ros oncogene 1, receptor tyrosine kinase-positive advanced lung adenocarcinoma: A case report. Oncology Letters. 8: 2624-2626. PMID 25364439 DOI: 10.3892/ol.2014.2571  0.56
2014 Chen Z, Li R, Xie Z, Huang G, Yuan Q, Zeng J. IL-6, IL-10 and IL-13 are associated with pathogenesis in children with Enterovirus 71 infection. International Journal of Clinical and Experimental Medicine. 7: 2718-23. PMID 25356130  0.32
2014 Zeng Z, Yan HH, Zhang XC, Zhong WZ, He YY, Guan JL, Niu FY, Xie Z, Huang YS, Xu CR, Dong S, Wu YL. Reduced chemotherapy sensitivity in EGFR-mutant lung cancer patient with frontline EGFR tyrosine kinase inhibitor. Lung Cancer (Amsterdam, Netherlands). 86: 219-24. PMID 25263853 DOI: 10.1016/j.lungcan.2014.09.008  0.6
2014 Wang F, Xie Z, Chen Z. High capacity reversible watermarking for audio by histogram shifting and predicted error expansion. Thescientificworldjournal. 2014: 656251. PMID 25097883 DOI: 10.1155/2014/656251  0.32
2014 Liu J, Li Y, Wei L, Yang X, Xie Z, Jiang T, Wang C, Zhang X, Xu D, Chen Z, Yang F, Li JC. Screening and identification of potential biomarkers and establishment of the diagnostic serum proteomic model for the Traditional Chinese Medicine Syndromes of tuberculosis. Journal of Ethnopharmacology. 155: 1322-31. PMID 25072359 DOI: 10.1016/j.jep.2014.07.025  0.36
2014 Liang W, Ye W, Ye D, Zhou Z, Chen Z, Li A, Xie ZH, Zhang L, Xu J. Construction and biomechanical properties of polyaxial self-locking anatomical plate based on the geometry of distal tibia. Biomed Research International. 2014: 436325. PMID 25025051 DOI: 10.1155/2014/436325  0.32
2014 Yang JJ, Zhang XC, Su J, Xu CR, Zhou Q, Tian HX, Xie Z, Chen HJ, Huang YS, Jiang BY, Wang Z, Wang BC, Yang XN, Zhong WZ, Nie Q, et al. Lung cancers with concomitant EGFR mutations and ALK rearrangements: diverse responses to EGFR-TKI and crizotinib in relation to diverse receptors phosphorylation. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 1383-92. PMID 24443522 DOI: 10.1158/1078-0432.CCR-13-0699  0.6
2013 Fei SJ, Zhang XC, Dong S, Cheng H, Zhang YF, Huang L, Zhou HY, Xie Z, Chen ZH, Wu YL. Targeting mTOR to overcome epidermal growth factor receptor tyrosine kinase inhibitor resistance in non-small cell lung cancer cells. Plos One. 8: e69104. PMID 23874880 DOI: 10.1371/journal.pone.0069104  0.6
2013 Jiang BY, Zhang XC, Su J, Meng W, Yang XN, Yang JJ, Zhou Q, Chen ZY, Chen ZH, Xie Z, Chen SL, Wu YL. BCL11A overexpression predicts survival and relapse in non-small cell lung cancer and is modulated by microRNA-30a and gene amplification. Molecular Cancer. 12: 61. PMID 23758992 DOI: 10.1186/1476-4598-12-61  0.6
2013 Bai XY, Lin JY, Zhang XC, Xie Z, Yan HH, Chen ZH, Xu CR, An SJ, Sheng GM, Wu YL. High expression of truncated GLI3 is associated with poor overall survival in patients with non-small cell lung cancer. Cancer Biomarkers : Section a of Disease Markers. 13: 37-47. PMID 23736020 DOI: 10.3233/CBM-130312  0.6
2012 Wang B, Yang J, Luo D, Qiao H, Xie Z, Zhang X, Wu Y. Complete remission and fatal interstitial pneumonitis related to nab-paclitaxel in refractory small cell lung cancer: A case report and review of the literature. Thoracic Cancer. 3: 84-87. PMID 28920260 DOI: 10.1111/j.1759-7714.2011.00086.x  0.36
2012 An SJ, Lin QX, Chen ZH, Su J, Cheng H, Xie Z, Zhang XC, Zhou HY, Huang Y, Chen SL, Guo WB, Wu YL. Combinations of laminin 5 with PTEN, p-EGFR and p-Akt define a group of distinct molecular subsets indicative of poor prognosis in patients with non-small cell lung cancer. Experimental and Therapeutic Medicine. 4: 226-230. PMID 23139712 DOI: 10.3892/etm.2012.577  0.6
2012 Dong S, Zhang XC, Cheng H, Zhu JQ, Chen ZH, Zhang YF, Xie Z, Wu YL. Everolimus synergizes with gefitinib in non-small-cell lung cancer cell lines resistant to epidermal growth factor receptor tyrosine kinase inhibitors. Cancer Chemotherapy and Pharmacology. 70: 707-16. PMID 22941374 DOI: 10.1007/s00280-012-1946-3  0.6
2011 Nie Q, An S, Yang X, Zhong W, Liao R, Yang J, Zhang X, Chen Z, Su J, Xie Z, Huang Y, Wu YL. CYP1A1*2A polymorphism as a prognostic factor for the advanced lung cancer patients treated with EGFR-TKI and its correlation with EGFR mutation. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: e13098. PMID 28019730 DOI: 10.1200/jco.2011.29.15_suppl.e13098  0.6
2011 Nie Q, Yang XN, An SJ, Zhang XC, Yang JJ, Zhong WZ, Liao RQ, Chen ZH, Su J, Xie Z, Wu YL. CYP1A1*2A polymorphism as a predictor of clinical outcome in advanced lung cancer patients treated with EGFR-TKI and its combined effects with EGFR intron 1 (CA)n polymorphism. European Journal of Cancer (Oxford, England : 1990). 47: 1962-70. PMID 21616658 DOI: 10.1016/j.ejca.2011.04.018  0.6
2010 Zhang X, Zhang S, Yang X, Yang J, Zhou Q, Yin L, An S, Lin J, Chen S, Xie Z, Zhu M, Zhang X, Wu YL. Fusion of EML4 and ALK is associated with development of lung adenocarcinomas lacking EGFR and KRAS mutations and is correlated with ALK expression. Molecular Cancer. 9: 188. PMID 20624322 DOI: 10.1186/1476-4598-9-188  0.6
2010 Dong S, Guo AL, Chen ZH, Wang Z, Zhang XC, Huang Y, Xie Z, Yan HH, Cheng H, Wu YL. RRM1 single nucleotide polymorphism -37C-->A correlates with progression-free survival in NSCLC patients after gemcitabine-based chemotherapy. Journal of Hematology & Oncology. 3: 10. PMID 20226083 DOI: 10.1186/1756-8722-3-10  0.6
2008 An S, Wu Y, Zhu J, Chen Z, Zhang G, Wang Z, Xie Z, Chen S, Huang Y, Guo A, Lin J. Elevated expression level of laminin 5 γ2 chain may be a negative predictive factor for the response to gefitinib in lung cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 14664. PMID 27949486 DOI: 10.1200/jco.2008.26.15_suppl.14664  0.36
2008 Li R, An SJ, Chen ZH, Zhang GC, Zhu JQ, Nie Q, Xie Z, Guo AL, Mok TS, Wu YL. Expression of cyclin D1 splice variants is differentially associated with outcome in non-small cell lung cancer patients. Human Pathology. 39: 1792-801. PMID 18715616 DOI: 10.1016/j.humpath.2008.05.008  0.6
2007 An SJ, Nie Q, Chen ZH, Lin QX, Wang Z, Xie Z, Chen SL, Huang Y, Zhang AY, Yan JF, Wu HS, Lin JY, Li R, Zhang XC, Guo AL, et al. KDR expression is associated with the stage and cigarette smoking of the patients with lung cancer. Journal of Cancer Research and Clinical Oncology. 133: 635-42. PMID 17479290 DOI: 10.1007/s00432-007-0214-0  0.6
Show low-probability matches.